Date of Award
Bachelor of Science
Biochemistry & Molecular Biol.
Dr. Mike Norris
Photoactivated chemotherapy (PACT) offers a targeted approach to cancer treatment through selective drug activation. Substitutionally labile ruthenium-based prodrugs undergo ligand-loss when irradiated, producing an unbound ligand and a Ru-aqua complex. We report the synthesis and cytotoxicity of several new ruthenium-centered complexes and their irradiation products for use in PACT. A series of complexes were synthesized in order to study the effects of structural differences on cell viability. Cell viability was tested on T47D human breast cancer cells in the presence of compound to determine cytotoxicity and dose-response. While neither the Rucomplexes nor their ligands demonstrated cytotoxicity, their Ru-aqua dissociation complexes all demonstrated cytotoxic effects at increasing concentrations. The results indicate the potential for the synthesized Ru-complexes to be used in PACT.
Paul, Lindsey, "Design of New Ruthenium Complexes for Photoactivated Chemotherapy" (2020). Honors Theses. 1504.